Precision radiation boosts tumor attack in advanced lung cancer trial
NCT ID NCT01629498
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 26 times
Summary
This study tests whether giving a higher radiation dose directly to the tumor, while keeping the dose to nearby healthy organs standard, is safe and effective for people with stage II to III non-small cell lung cancer. It uses advanced imaging to guide either photon (IMRT) or proton (IMPT) radiation, both given with chemotherapy. The trial includes 146 participants and aims to find the best dose that limits side effects like esophagitis and pneumonitis while improving local tumor control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT LUNG NON-SMALL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.